These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The prion protein in human neurodegenerative disorders. Kovacs GG, Zerbi P, Voigtländer T, Strohschneider M, Trabattoni G, Hainfellner JA, Budka H. Neurosci Lett; 2002 Sep 06; 329(3):269-72. PubMed ID: 12183028 [Abstract] [Full Text] [Related]
24. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies. Ferrer I, Hernández I, Boada M, Llorente A, Rey MJ, Cardozo A, Ezquerra M, Puig B. Acta Neuropathol; 2003 Nov 06; 106(5):419-35. PubMed ID: 12955398 [Abstract] [Full Text] [Related]
27. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases. Yokota O, Terada S, Ishizu H, Ujike H, Ishihara T, Namba M, Hayashi Y, Nishinaka T, Namba R, Nakashima H, Uéda K, Checler F, Kuroda S. Acta Neuropathol; 2003 Oct 06; 106(4):348-56. PubMed ID: 12883830 [Abstract] [Full Text] [Related]
28. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E. Am J Pathol; 1998 Feb 06; 152(2):367-72. PubMed ID: 9466562 [Abstract] [Full Text] [Related]
31. Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein. Giasson BI, Duda JE, Quinn SM, Zhang B, Trojanowski JQ, Lee VM. Neuron; 2002 May 16; 34(4):521-33. PubMed ID: 12062037 [Abstract] [Full Text] [Related]
32. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ, Lee VM. Science; 2000 Nov 03; 290(5493):985-9. PubMed ID: 11062131 [Abstract] [Full Text] [Related]
33. The significance of tau and alpha-synuclein inclusions in neurodegenerative diseases. Goedert M. Curr Opin Genet Dev; 2001 Jun 03; 11(3):343-51. PubMed ID: 11377973 [Abstract] [Full Text] [Related]
34. Neuropathology of primary restless leg syndrome: absence of specific tau- and alpha-synuclein pathology. Pittock SJ, Parrett T, Adler CH, Parisi JE, Dickson DW, Ahlskog JE. Mov Disord; 2004 Jun 03; 19(6):695-9. PubMed ID: 15197711 [Abstract] [Full Text] [Related]
36. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease? Armstrong RA, Lantos PL, Cairns NJ. Neuropathology; 2008 Aug 03; 28(4):351-65. PubMed ID: 18433435 [Abstract] [Full Text] [Related]
37. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias. Parnetti L, Chiasserini D, Bellomo G, Giannandrea D, De Carlo C, Qureshi MM, Ardah MT, Varghese S, Bonanni L, Borroni B, Tambasco N, Eusebi P, Rossi A, Onofrj M, Padovani A, Calabresi P, El-Agnaf O. Mov Disord; 2011 Jul 03; 26(8):1428-35. PubMed ID: 21469206 [Abstract] [Full Text] [Related]
38. Patterns of Tau and α-Synuclein Pathology in the Visual System. Rahimi J, Milenkovic I, Kovacs GG. J Parkinsons Dis; 2015 Jul 03; 5(2):333-40. PubMed ID: 25737267 [Abstract] [Full Text] [Related]
39. Dementia with Lewy bodies from the perspective of tauopathy. Iseki E, Togo T, Suzuki K, Katsuse O, Marui W, de Silva R, Lees A, Yamamoto T, Kosaka K. Acta Neuropathol; 2003 Mar 03; 105(3):265-70. PubMed ID: 12557014 [Abstract] [Full Text] [Related]
40. Alpha-synuclein: normal function and role in neurodegenerative diseases. Norris EH, Giasson BI, Lee VM. Curr Top Dev Biol; 2004 Mar 03; 60():17-54. PubMed ID: 15094295 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]